Question 1

Has Gary Fink received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $6,917,136 in general payments to Gary Fink across 409 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Gary Fink did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Gary Fink come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
American Rheumatology Network, LLC	18	$6,878,917
AbbVie	58	$32,148
Johnson & Johnson(2 entities)	85	$1,381
Amgen(2 entities)	50	$894
UCB, Inc.	29	$452
E.r. Squibb & Sons, L.L.C.	25	$425
Novartis	25	$380
Octapharma USA, Inc.	2	$331
GSK	19	$315
Pfizer	26	$310
Janssen Scientific Affairs, LLC	3	$296
AstraZeneca(2 entities)	11	$184
Aurinia Pharma U.S., Inc.	6	$146
Boehringer Ingelheim	9	$130
Radius Health, Inc.	6	$128
Genentech USA, Inc.	6	$125
Lilly USA, LLC	7	$109
Biogen	1	$103
Merck	6	$79
Organon	5	$77
Hikma Pharmaceuticals USA	4	$58
Regeneron Healthcare Solutions, Inc.	3	$48
Ultragenyx Pharmaceutical Inc.	2	$31
Boston Scientific	1	$30
Fresenius Kabi USA, LLC	1	$22
Sanofi	1	$16

Gary Fink

Payments from drug & device makers

Who reported the general payments

How this compares

Other rheumatology in Summerville